-
Wearing-off symptoms persist in the majority of patients with multiple sclerosis after switching from natalizumab to ocrelizumab
Gelissen, L. M. Y., Hogenboom, L., Toorop, A. A., Strijbis, E. M. M., van Oosten, B. W., de Jong, B. A., Killestein, J. & van Kempen, Z. L. E., 15 Dec 2025, In: Journal of the Neurological Sciences. 479, 125652.Research output: Contribution to journal › Article › Academic › peer-review
-
Erratum: Evolution of Cortical Lesions and Function-Specific Cognitive Decline in People With Multiple Sclerosis (Neurology (2025) 104 11 DOI: 10.1212/WNL.0000000000213650.)
Krijnen, E. A., Jelgerhuis, J., van Dam, M., Bouman, P. M., Koubiyr, I., Barkhof, F., Klawiter, E. C., Hulst, H. E., Strijbis, E. M. M. & Schoonheim, M. M., 25 Nov 2025, In: Neurology. 105, 10, p. e214158Research output: Contribution to journal › Comment/Letter to the editor › Academic
-
Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: A multinational, individual participant-level analysis
Abdelhak, A., Bachhuber, F., Ning, K., Benkert, P., John Boscardin, W., Maleska MacEski, A., Schaedelin, S., Achtnichts, L., Finkener, S., Lalive, P. H., Uginet, M., Pot, C., du Pasquier, R., Hoepner, R., Chan, A., Gobbi, C., Zecca, C., Müller, S., Roth, P. & Granziera, C. & 56 others, , 1 Nov 2025, In: J. Neurol. Neurosurg. Psychiatry. 96, 11, p. 1046-1052 7 p., jnnp-2025-335831.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
